Concepedia

Author

Christoph Dahlhoff

Amgen (United States)

Also Known As

Christoph Dahlhoff

8

Publications

134

Citations

5

H-Index

5

Concepts

All Affiliations

Amgen (United States)Amgen (Germany)
CD

About

Christoph Dahlhoff is an author at Amgen (United States) specializing in medicine, cellular physiology, and allergy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

35

2

Allergy

1

1

35

3

Cellular Physiology

1

1

35

4

Immunopathology

1

1

35

5

Molecular Physiology

1

1

35

Christoph Dahlhoff

×

4

Publications

119

Citations

4

H-Index

YearCitations

Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid Leukemia

Bettina Brauchle, Rebecca Goldstein, Christine M. Karbowski,

Molecular Cancer Therapeutics

2020

50

Upregulated expression of ENaC in human CF nasal epithelium

Nadine Bangel, Christoph Dahlhoff, Katja Sobczak,

Journal of Cystic Fibrosis

2007

35

Generation of a Half-Life Extended Anti-CD19 BiTE® Antibody Construct Compatible with Once-Weekly Dosing for Treatment of CD19-Positive Malignancies

Grit Lorenczewski, Matthias Friedrich, Roman Kischel,

Blood

2017

24

Preclinical Assessment of a MUC12-Targeted BiTE (Bispecific T-cell Engager) Molecule

Elizabeth Pham, Matthias G. Friedrich, Famke Aeffner,

Molecular Cancer Therapeutics

2021

10

Page 1